FDA Panel Calls for Mandatory Opioid Training

Physicians who prescribe opioid pain medications would have to undergo a higher level of specific training under a guidance recommended by a Food and Drug Administration advisory panel. In response to a perceived epidemic of opioid addiction and related deaths, the panel voted unanimously to advice requiring more education about the drugs’ risks. The panel’s vote was unanimous, but not binding—though the FDA does often follow recommendations made by its outside expert panels.